Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÃøµÎÇϾÇÀå¾Ö ȯÀÚ¿¡¼­ ÀåÄ¡Ä¡·á Å×ÀÌÆÛ¸µ ¹× Á¾·á½Ã±â¿¡ ´ëÇÑ ºÐ¼®

Analysis of splint weaning in temporomandibular disorder patients

±¸°­È¸º¹ÀÀ¿ë°úÇÐÁö 2021³â 37±Ç 4È£ p.225 ~ 231
±èº¹À½, ¹Î°­·Ä, ±èÇüÅÃ, ¾ÈÇüÁØ, ±è¼ºÅÃ,
¼Ò¼Ó »ó¼¼Á¤º¸
±èº¹À½ ( Kim Bok-Eum ) - Yonsei University College of Dentistry Department of Orofacial Pain and Oral Medicine
¹Î°­·Ä ( Min Kang-Ryul ) - Lake Forest College Department of Biology
±èÇüÅà( Kim Hyung-Tack ) - TMJ & Orofacial Pain Center
¾ÈÇüÁØ ( Ahn Hyung-Joon ) - Yonsei University College of Dentistry Department of Orofacial Pain and Oral Medicine
±è¼ºÅà( Kim Seong-Taek ) - Yonsei University College of Dentistry Department of Orofacial Pain and Oral Medicine

Abstract

¸ñÀû: ÃøµÎÇϾÇÀå¾Ö ȯÀÚ¿¡°Ô ÁÖ·Î »ç¿ëµÇ´Â ÀåÄ¡ Ä¡·áÀÇ ÀûÀÀÁõ ¹× È¿°ú¿¡ ´ëÇÑ ¿¬±¸´Â ´Ù¼ö Á¸ÀçÇϳª, Áõ»ó °³¼±¿¡ µû¶ó ÀåÄ¡¸¦ Å×ÀÌÆÛ¸µÇÏ¿© Á¾·áÇÏ´Â ¹æ¹ý¿¡ ´ëÇÑ ¿¬±¸´Â ºÎÁ·ÇÏ´Ù. µû¶ó¼­ º» ÈÄÇâÀû ¿¬±¸´Â ÃøµÎÇϾÇÀå¾Ö ȯÀÚ¸¦ ´ë»óÀ¸·Î, Áõ»ó °³¼±¿¡ µû¶ó ÀåÄ¡¸¦ Å×ÀÌÆÛ¸µÇÏ¿© Á¾·áÇÏ´Â °úÁ¤À» °íÂûÇÏ°íÀÚ ÇÑ´Ù.

¿¬±¸ Àç·á ¹× ¹æ¹ý: ÅΰüÀý Áúȯ, ±Ù¸· ÅëÁõ, ÀÌ°¥ÀÌ ¹× À̾ǹ°±â µîÀ» ÁÖ¼Ò·Î ¿¬¼¼´ëÇб³ Ä¡°ú´ëÇк´¿ø ±¸°­³»°ú¸¦ ³»¿øÇÏ¿© ÀåÄ¡ Ä¡·á(±³ÇÕ¾ÈÁ¤ÀåÄ¡, Àü¹æÀ§Ä¡±³ÇÕÀåÄ¡)¸¦ ½ÃÇàÇÑ 130¸íÀÇ È¯ÀÚÀÇ Â÷Æ® ¸®ºä¸¦ ÅëÇØ ÀåÄ¡ Ä¡·á¸¦ Å×ÀÌÆÛ¸µÇÏ¿© Á¾·áÇÏ´Â °úÁ¤À» ¾Ë¾Æº¸¾Ò´Ù.

°á°ú: Æò±Õ ÀåÄ¡ ÀåÂø ±â°£Àº 29°³¿ù·Î, ¸ÅÀÏ ÀåÄ¡¸¦ ÀåÂøÇÑ ±â°£Àº 8.4°³¿ù, ÀÏÁÖÀÏ¿¡ 3 - 4ÀÏ°£ ÀåÄ¡¸¦ ÀåÂøÇÑ ±â°£Àº 9.5°³¿ù, ÀÏÁÖÀÏ¿¡ 1 - 2ÀÏ°£ ÀåÄ¡¸¦ ÀåÂøÇÑ ±â°£Àº 11.1°³¿ùÀ̾ú´Ù.

°á·Ð: ÃøµÎÇϾÇÀå¾Ö ȯÀÚ¿¡¼­ ÀåÄ¡ ÀåÂø ½Ã óÀ½ 6°³¿ù °£Àº ¸ÅÀÏ ÀåÂø, ÀÌÈÄ 6°³¿ù¿¡¼­ 18°³¿ù µ¿¾ÈÀº ÀÏÁÖÀÏ¿¡ 3 - 4ÀÏ°£ ÀåÂø, 18°³¿ù ÀÌÈĺÎÅÍ´Â ÀÏÁÖÀÏ¿¡ 1 - 2ÀÏ°£ ÀåÂøÇÏ´Â ¹æ½ÄÀ¸·Î Å×ÀÌÆÛ¸µÇÏ¿© ÀåÄ¡ Ä¡·á¸¦ Á¾·áÇÒ ½Ã ÃøµÎÇϾÇÀå¾Ö ȯÀÚÀÇ Áõ»óÀº ¿ÏÈ­½ÃÅ°¸é¼­ ±³ÇÕ º¯È­ µîÀÇ ºÎÀÛ¿ëÀº ÃÖ¼ÒÈ­½Ãų ¼ö ÀÖÀ» °ÍÀ¸·Î »ç·áµÈ´Ù.

Purpose: There are many studies on the indications and efficacy of splint therapy commonly used in patients with temporomandibular disorders (TMD). However, there have been no studies on the splint weaning in terms of the splint use tapering period in relation to symptom improvement of TMD. This retrospective study aims to analyze a proper splint weaning method in patients with TMD based on symptom improvement.

Materials and Methods: The authors examined 130 TMD patients with TMJ disorders, masticatory muscle disorders, and clenching/bruxism who had received splint therapy (occlusion stabilization splint, anterior positioning splint) of patients who visited the Department of Orofacial Pain and Oral Medicine at Yonsei University Dental Hospital from 2015 to 2020. They were evaluated according to the method to wean splints.

Results: The mean splint therapy period was 29.0 months, during which patients wore splints 7 days a week for 8.4 months, 3 - 4 days a week for 9.5 months, and finally 1 - 2 days a week for 11.1 months (a total of 29.0 months, about 2.5 years).

Conclusion: It seems that TMD symptoms can be alleviated and side effects such as occlusal change can be minimized if patients wear a splint 7 days a week for the first 6 months, followed by 3 - 4 days a week for the next 6 to 18 months, and finally 1 - 2 days a week after 18 months.

Å°¿öµå

ÃøµÎÇϾÇÀå¾Ö; ±³ÇÕ¾ÈÁ¤ÀåÄ¡; Àü¹æÀ§Ä¡±³ÇÕÀåÄ¡
temporomandibular disorders; occlusion stabilization splint; anterior positioning splint

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

µîÀçÀú³Î Á¤º¸

KCI